abstract |
The present invention relates to the crystalline form of 6 - [(2,2-diphenylethyl) amino] -9- (N-ethyl-β-D-ribofuranosyluronamide) -N- (2- {N '- [1- (2-pyridyl) -4-piperidyl] ureido} ethyl) -9H-purine-2-carboxamide and to the method of its production, compositions containing it and to the use of this crystalline form. The international application was published together with an international search report. |